Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Single Tube Molecular Profiling of ALL Samples Reveals Integrated Molecular Signature and Highlights Gene Regulatory Networks

Lina Zelinger, Samuel Koo, Francys Alarcon, Charmeine Ko, Brad B Thomas, Segun C Jung, Ying Wang, Fei Ye, Shashikant Kulkarni

Blood (2022) 140 (Supplement 1): 11870–11871.

https://doi.org/10.1182/blood-2022-166932

Published: 2022

Journal Articles

Expert Curation of Somatic FLT3 Variants By the Clingen Somatic Hematologic Cancer Taskforce (ClinGen HCT)

Blood (2021) 138 (Supplement 1): 4387.

https://doi.org/10.1182/blood-2021-153546

Published: 2021

Journal Articles

Expert Variant Curation Combined with in-Silico analysis for Clinical Interpretation of BCL2 variants in Resistance to BCL2 Inhibitors in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Matthew McCoy, PhD, Shruti Rao, MS, MBA, Shannon Cosgrove, MS, Subha Madhavan, PhD, Shashikant Kulkarni, MS, PhD FACMG, Xinjie Xu, PhD, Rashmi Kanagal-Shamanna, MD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-143073

Published: 2020

Journal Articles

Expert Curation of Somatic Variants in Hematological Malignancies By the Clingen Somatic Hematological Cancer Taskforce (ClinGen HCT)

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-143028

Published: 2020

Journal Articles

Plerixafor, G-CSF and Azacitidine For The Treatment Of MDS: Results Of a Phase I Trial

Mark A. Schroeder, MD, Marcus Grillot, Teresa Reineck, Meagan A Jacoby, MD/PhD, Rizwan Romee, MD, Iskra Pusic, MD, John Welch, MD/PhD, Geoffrey L. Uy, MD, Amanda F Cashen, MD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Shashikant Kulkarni, PhD, Peter Westervelt, MD, PhD, Matthew J. Walter, MD, John F. Dipersio, MD, PhD

Blood (2013) 122 (21): 2816.

https://doi.org/10.1182/blood.V122.21.2816.2816

Published: 2013

Journal Articles

Whole Genome Sequencing Reveals Novel Recurring Somatic Mutations Affecting HUWE1 and DIAPH2 Genes in Multiple Myeloma

Michael H. Tomasson, MD, Dong Shen, PhD, Vishwanathan Hucthagowder, PhD, William Schierding, B.S., Chelsea D. Mullins, BSci, Mark Fiala, BS, CCRP, Ira M Hall, PhD, John Wallis, PhD, Robert S. Fulton, Lucinda A. Fulton, MS, Shashikant Kulkarni, PhD, Elaine R. Mardis, PhD, Richard K Wilson, Timothy J. Ley, John F. DiPersio, MD, PhD, Christopher A. Maher, PhD, Ravi Vij, MD, Li Ding

Blood (2012) 120 (21): 320.

https://doi.org/10.1182/blood.V120.21.320.320

Published: 2012

Journal Articles

Activation of K-Ras in Arf-Null Mice Is Not Sufficient for Malignant Transformation of Post-Germinal Center B-Cells

Chelsea D. Mullins, BSci, Mack Y. Su, Vishwanathan Hucthagowder, PhD, Liang Chu, PhD, Lan Lu, MSci, Shashikant Kulkarni, PhD, Ravi Vij, MD, Michael H. Tomasson, MD

Blood (2012) 120 (21): 5016.

https://doi.org/10.1182/blood.V120.21.5016.5016

Published: 2012

Journal Articles

Genome-Wide Copy Number Analyses Correlated with Outcomes in Untreated Multiple Myeloma Patients

Vishwanathan Hucthagowder, PhD, Mark Fiala, BS, CCRP, Doug Cox, BS, Keith E. Stockerl-Goldstein, MD, Michael H. Tomasson, MD, John F. DiPersio, MD, PhD, Ravi Vij, MD, Shashikant Kulkarni, PhD

Blood (2012) 120 (21): 3991.

https://doi.org/10.1182/blood.V120.21.3991.3991

Published: 2012

Journal Articles

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Geoffrey L. Uy, Michael P. Rettig, Ibraheem H. Motabi, Kyle McFarland, Kathryn M. Trinkaus, Lindsay M. Hladnik, Shashikant Kulkarni, Camille N. Abboud, Amanda F. Cashen, Keith E. Stockerl-Goldstein, Ravi Vij, Peter Westervelt, John F. DiPersio

Blood (2012) 119 (17): 3917–3924.

https://doi.org/10.1182/blood-2011-10-383406

Published: 2012

Includes: Supplemental data

Journal Articles

Detection of FLT3 Internal Tandem Duplications in Acute Myeloid Leukemia by Targeted Multi-Gene Next Generation Sequencing,

David H Spencer, MD/PhD, Haley Abel, Ph.D., Philippe Szankasi, PhD, Todd W. Kelley, MD, Shashikant Kulkarni, PhD, Mark A. Watson, MD, PhD, John D Pfeifer, MD, PhD, Eric J. Duncavage, MD

Blood (2011) 118 (21): 3547.

https://doi.org/10.1182/blood.V118.21.3547.3547

Published: 2011

Journal Articles

Genomic Landscape of Immunoglobulin Light Chain (AL) Amyloidosis and Comparative Analyses with Related Malignant Plasma Cell Disorder- Multiple Myeloma

Vishwanathan Hucthagowder, PhD, Jahangheer Shaik, PhD, Mark Fiala, BS, Jacob Paasch, BS, Rakesh Nagarajan, MD, PhD, Keith E. Stockerl-Goldstein, MD, John F. DiPersio, MD, PhD, Michael H. Tomasson, MD, Ravi Vij, MD, Shashikant Kulkarni, PhD

Blood (2011) 118 (21): 809.

https://doi.org/10.1182/blood.V118.21.809.809

Published: 2011

Journal Articles

High Throughput Digital Quantification of Genomic Copy Number Alterations in Multiple Myeloma

Shashikant Kulkarni, PhD, Nathan Elliott, PhD, Mark Fiala, BS, Jacob Paasch, BS, Michael H. Tomasson, MD, Keith E. Stockerl-Goldstein, MD, John F. DiPersio, MD, PhD, Gary Geiss, PhD, Ravi Vij, MD, Vishwanathan Hucthagowder, PhD

Blood (2011) 118 (21): 1830.

https://doi.org/10.1182/blood.V118.21.1830.1830

Published: 2011

Journal Articles

Resequencing Analysis of the Human Candidate Ras and Receptor Tyrosine Kinase Gene Family In Multiple Myeloma

Vishwanathan Hucthagowder, PhD, Chelsea D. Mullins, BSci, Rekha Meyer, PhD, Rakesh Nagarajan, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MBBS, MD, Michael H. Tomasson, MD, Shashikant Kulkarni, PhD, FACMG

Blood (2010) 116 (21): 301.

https://doi.org/10.1182/blood.V116.21.301.301

Published: 2010

Journal Articles

Resolution of a Clinical Dilemma with Whole Genome Sequencing, and Discovery of a New Mechanism for Generating PML-Rara: Insertional Fusion

John S. Welch, MD, PhD, Li Ding, PhD, Ken Chen, PhD, David E. Larson, PhD, Shashikant Kulkarni, PhD, Jacqueline E. Payton, MD, PhD, John Wallis, PhD, Joelle Veizer, BS, Michael D. McLellan, Tammi L. Vickery, BS, Jerry P. Reed, MS, Daniel C Koboldt, MS, Jeffery Klco, MD, John F. DiPersio, MD, PhD, Elaine R. Mardis, PhD, Timothy J Ley, MD, Richard K. Wilson, PhD, Peter Westervelt, MD, PhD

Blood (2010) 116 (21): 2755.

https://doi.org/10.1182/blood.V116.21.2755.2755

Published: 2010

Journal Articles

DNA Sequence of the Cancer Genome of a Patient with Therapy-Related Acute Myeloid Leukemia

Blood (2010) 116 (21): 580.

https://doi.org/10.1182/blood.V116.21.580.580

Published: 2010

Journal Articles

Germinal Center Specific Activation of K-Ras, Common In Multiple Myeloma, Is Selected Against and Is Not Sufficient to Initiate Plasma Cell Transformation In Mice

Chelsea D. Mullins, BSci, Michael Tomasson, MD, Lan Lu, MSci, Mack Y. Su, Vishwanathan Hutchagowder, PhD, Ravi Vij, MBBS, MD, Shashikant Kulkarni, PhD, Liang Chu, PhD

Blood (2010) 116 (21): 137.

https://doi.org/10.1182/blood.V116.21.137.137

Published: 2010

Journal Articles

A Phase I/II Study of Chemosensitization with the CXCR4 Antagonist Plerixafor in Relapsed or Refractory AML.

Geoffrey L. Uy, MD, Michael P. Rettig, PhD, Kyle McFarland, Lindsay Hladnik, PharmD, Shashikant Kulkarni, PhD, Camille N. Abboud, MD, Amanda F Cashen, MD, Keith Stockerl-Goldstein, MD, Ravi Vij, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD

Blood (2009) 114 (22): 787.

https://doi.org/10.1182/blood.V114.22.787.787

Published: 2009

Journal Articles

Mobilization and Chemosensitization of AML with the CXCR4 Antagonist Plerixafor (AMD3100): A Phase I/II Study of AMD3100+MEC in Patients with Relapsed or Refractory Disease.

Geoffrey L. Uy, MD, Michael P. Rettig, PhD, Kyle M. McFarland, Lindsay M. Hladnik, PharmD, Shashikant Kulkarni, PhD, Camille N. Abboud, MD, Amanda F. Cashen, MD, Keith Stockerl-Goldstein, MD, Ravi Vij, MBBS, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD

Blood (2008) 112 (11): 1944.

https://doi.org/10.1182/blood.V112.11.1944.1944

Published: 2008

Journal Articles

Accelerated Shortening of Long Telomeres and Accumulation of Short Telomeres in Dyskeratosis Congenita.

Monica Bessler, MD, PhD, Rachida Bouharich, Shashikant Kulkarni, PhD, Sara Freeman, Hong-Yan Du, MD, PhD, Philip J. Mason, PhD, Arturo Londono-Vallejo, MD, PhD, Fred Goldman, MD.

Blood (2005) 106 (11): 1053.

https://doi.org/10.1182/blood.V106.11.1053.1053

Published: 2005

Journal Articles

Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita

Matt Knudson, Shashikant Kulkarni, Zuhair K. Ballas, Monica Bessler, Frederick Goldman

Blood (2005) 105 (2): 682–688.

https://doi.org/10.1182/blood-2004-04-1673

Published: 2005

NARROW

Single Tube Molecular Profiling of ALL Samples Reveals Integrated Molecular Signature and Highlights Gene Regulatory Networks

Expert Curation of Somatic FLT3 Variants By the Clingen Somatic Hematologic Cancer Taskforce (ClinGen HCT)

Expert Variant Curation Combined with in-Silico analysis for Clinical Interpretation of BCL2 variants in Resistance to BCL2 Inhibitors in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma

Expert Curation of Somatic Variants in Hematological Malignancies By the Clingen Somatic Hematological Cancer Taskforce (ClinGen HCT)

Plerixafor, G-CSF and Azacitidine For The Treatment Of MDS: Results Of a Phase I Trial

Whole Genome Sequencing Reveals Novel Recurring Somatic Mutations Affecting HUWE1 and DIAPH2 Genes in Multiple Myeloma

Activation of K-Ras in Arf-Null Mice Is Not Sufficient for Malignant Transformation of Post-Germinal Center B-Cells

Genome-Wide Copy Number Analyses Correlated with Outcomes in Untreated Multiple Myeloma Patients

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Detection of FLT3 Internal Tandem Duplications in Acute Myeloid Leukemia by Targeted Multi-Gene Next Generation Sequencing,

Genomic Landscape of Immunoglobulin Light Chain (AL) Amyloidosis and Comparative Analyses with Related Malignant Plasma Cell Disorder- Multiple Myeloma

High Throughput Digital Quantification of Genomic Copy Number Alterations in Multiple Myeloma

Resequencing Analysis of the Human Candidate Ras and Receptor Tyrosine Kinase Gene Family In Multiple Myeloma

Resolution of a Clinical Dilemma with Whole Genome Sequencing, and Discovery of a New Mechanism for Generating PML-Rara: Insertional Fusion

DNA Sequence of the Cancer Genome of a Patient with Therapy-Related Acute Myeloid Leukemia

Germinal Center Specific Activation of K-Ras, Common In Multiple Myeloma, Is Selected Against and Is Not Sufficient to Initiate Plasma Cell Transformation In Mice

A Phase I/II Study of Chemosensitization with the CXCR4 Antagonist Plerixafor in Relapsed or Refractory AML.

Mobilization and Chemosensitization of AML with the CXCR4 Antagonist Plerixafor (AMD3100): A Phase I/II Study of AMD3100+MEC in Patients with Relapsed or Refractory Disease.

Accelerated Shortening of Long Telomeres and Accumulation of Short Telomeres in Dyskeratosis Congenita.

Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only